BMT — New Silkroutes Share Price
0.000.00%
Last trade - 00:00HealthcareBalancedMicro Cap
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -36.3% | ||
Financial Summary
| Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 605.02 | 49.53 | 42.04 | 39.93 | 28.25 | n/a | n/a | -47.26% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
New Silkroutes Group Limited is a Singapore-based investment holding company. The Company’s principal activities consist of distributing health supplements and Chinese medicine, manufacturing of non-woven fabric as well as providing clinical management services, health sciences consultants, dental services, management services and investment holding. The Company operates through two segments: Healthcare and Others. The Healthcare segment owns and operates clinics in Singapore providing complementary integrative therapies, runs employee healthcare benefits programs, offers systems integration services to hospitals and healthcare facilities, owns and operates clinics in Singapore providing dental services, and distributes dental and medical supplies, and manufacturing healthcare consumables. The Others segment consists of general corporate activities.
Directors
- Chee Lek Lim NEC (43)
- Hwei Pink Wong CEO (44)
- Luna Lee CEX
- Yuyun Shen EDR (54)
- Wu Guoliang OTH
- Artun Gursel OTH
- Beng Hong Ong SEC
- Siong Kiat Chua NID (50)
- Lim Seng NID
- Last Annual
- June 30th, 2023
- Last Interim
- September 30th, 2023
- Incorporated
- January 25th, 1994
- Public Since
- March 28th, 2002
- No. of Employees
- 331
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Singapore Exchange Securities Trading Ltd
- Shares in Issue
- 208,464,669
- Address
- 456 Alexandra Road, 119962
- Web
- https://www.newsilkroutes.org/
- Phone
- +65 63770100
- Auditors
- Baker Tilly TFW LLP
Upcoming Events for BMT
Half Year 2024 New Silkroutes Group Ltd Earnings Release
Q3 2024 New Silkroutes Group Ltd Earnings Release
Similar to BMT
Alliance Healthcare
Singapore Exchange Securities Trading Ltd
Aoxin Q & M Dental
Singapore Exchange Securities Trading Ltd
Asiamedic
Singapore Exchange Securities Trading Ltd
Asia Vets Holdings
Singapore Exchange Securities Trading Ltd
Beverly JCG
Singapore Exchange Securities Trading Ltd
FAQ
What is the New Silkroutes share price?
As of Today at 04:16 UTC, shares in New Silkroutes are trading at SG$0.08. This share price information is delayed by 15 minutes.
How has the New Silkroutes share price performed this year?
Shares in New Silkroutes last closed at SG$0.08 and the price had moved by -12.79% over the past 365 days. In terms of relative price strength the New Silkroutes share price has underperformed the FTSE Developed Asia Pacific Index by -17.26% over the past year.
What are the analyst and broker recommendations for New Silkroutes?
There is no consensus recommendation for this security.
Find out moreWhat is the New Silkroutes dividend yield?
New Silkroutes does not currently pay a dividend.
Does New Silkroutes pay a dividend?
New Silkroutes does not currently pay a dividend.
When does New Silkroutes next pay dividends?
New Silkroutes does not currently pay a dividend.
How do I buy New Silkroutes shares?
To buy shares in New Silkroutes you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of New Silkroutes?
As of the previous close price of SG$0.08, shares in New Silkroutes had a market capitalisation of .
Where are New Silkroutes shares listed?
Here are the trading details for New Silkroutes:
- Country of listing: Singapore
- Exchange: SES
- Ticker Symbol: BMT
What kind of share is New Silkroutes?
Based on an overall assessment of its quality, value and momentum New Silkroutes is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a New Silkroutes share price forecast for 2024?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the New Silkroutes share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like New Silkroutes. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -47.29%.
As of the last closing price of SG$0.08, shares in New Silkroutes were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the New Silkroutes PE Ratio?
The New Silkroutes PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SG$0.08.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of New Silkroutes?
New Silkroutes' management team is headed by:
- Chee Lek Lim - NEC
- Hwei Pink Wong - CEO
- Luna Lee - CEX
- Yuyun Shen - EDR
- Wu Guoliang - OTH
- Artun Gursel - OTH
- Beng Hong Ong - SEC
- Siong Kiat Chua - NID
- Lim Seng - NID